-
Mashup Score: 3Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma - Arlene Siefker-Radtke - 6 day(s) ago
Sam Chang engages with Arlene Siefker-Radtke to explore the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer. Dr. Siefker-Radtke illuminates the targeted approach of erdafitinib, emphasizing its efficacy in hitting specific genetic alterations, particularly FGFR3/2 mutations, prevalent in 15-20% of metastatic bladder tumors. Highlighting the drug’s…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 8The Quickly Evolving Treatment Landscape of Metastatic Urothelial Carcinoma: A New Standard of Care in First-Line Systemic Therapy - 8 day(s) ago
bladder cancer, metastatic urothelial carcinoma, EV-302 trial, KEYNOTE-A39 study, enfortumab vedotin, pembrolizumab, enfortumab vedotin plus pembrolizumab, CheckMate 901 study, nivolumab plus gemcitabine/cisplatin, nivolumab, gemcitabine, antibody-drug conjugate targeting Nectin-4, NCT04223856, methotrexate, vinblastine, doxorubicin, MVAC, Avelumab, JAVELIN bladder 100, APOBEC mutation signatures, KEYNOTE-B15 study, EV-304 trial, NCT04700124.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
The quickly evolving treatment landscape of metastatic #UrothelialCarcinoma: a new standard of care in first-line systemic therapy. @zklaassen_md @GACancerCenter and @RKSayyid @UofT review developments in the treatment of metastatic urothelial carcinoma > https://t.co/tHLKCAYyHz https://t.co/swtKJ2Lsaz
-
-
Mashup Score: 1ICI Outcomes Better in PD-L1-Positive Metastatic Urothelial Carcinoma - Oncology Nurse Advisor - 1 month(s) ago
Investigators report findings from a systematic review and meta-analysis of 14 studies.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma - Arlene Siefker-Radtke - 1 month(s) ago
Sam Chang engages with Arlene Siefker-Radtke to explore the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer. Dr. Siefker-Radtke illuminates the targeted approach of erdafitinib, emphasizing its efficacy in hitting specific genetic alterations, particularly FGFR3/2 mutations, prevalent in 15-20% of metastatic bladder tumors. Highlighting the drug’s…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Erdafitinib or chemotherapy in advanced or metastatic #UrothelialCarcinoma. Arlene Siefker-Radtke @MDAndersonNews joins @UroCancerMD @VUMCurology to discuss the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer > https://t.co/epYXJJTgk8 https://t.co/qrnDWeT0mb
-
-
Mashup Score: 8The Quickly Evolving Treatment Landscape of Metastatic Urothelial Carcinoma: A New Standard of Care in First-Line Systemic Therapy - 1 month(s) ago
bladder cancer, metastatic urothelial carcinoma, EV-302 trial, KEYNOTE-A39 study, enfortumab vedotin, pembrolizumab, enfortumab vedotin plus pembrolizumab, CheckMate 901 study, nivolumab plus gemcitabine/cisplatin, nivolumab, gemcitabine, antibody-drug conjugate targeting Nectin-4, NCT04223856, methotrexate, vinblastine, doxorubicin, MVAC, Avelumab, JAVELIN bladder 100, APOBEC mutation signatures, KEYNOTE-B15 study, EV-304 trial, NCT04700124.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
The quickly evolving treatment landscape of metastatic #UrothelialCarcinoma: a new standard of care in first-line systemic therapy. @zklaassen_md @GACancerCenter and @RKSayyid @UofT review developments in the treatment of metastatic urothelial carcinoma > https://t.co/tHLKCAYyHz https://t.co/swtKJ2Lsaz
-
-
Mashup Score: 2
Ashish Kamat welcomes Charles Guo to discuss variant histology in bladder urothelial carcinoma, which constitutes about 90% of all bladder cancers. Dr. Guo meticulously explains the WHO classification into noninvasive and invasive types, detailing distinguishing features, aggressive behaviors, and distinct genomic alterations of various subtypes like micropapillary, plasmacytoid, and small cell…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4Overcoming Upper Tract Urothelial Carcinoma: Michael Miller's Journey with JELMYTO® Treatment - Michael Miller - 4 month(s) ago
Diagnosed with upper tract urothelial carcinoma, Michael Miller is initially shaken by the possibility of losing his kidney. However, he finds a less invasive alternative with JELMYTO®, a treatment offered at the Georgia Cancer Center. The process involves six weekly infusions, with minimal discomfort and disruption to his daily life. Despite a minor infection, the procedure is smooth, and he…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
Ashish Kamat welcomes Charles Guo to discuss variant histology in bladder urothelial carcinoma, which constitutes about 90% of all bladder cancers. Dr. Guo meticulously explains the WHO classification into noninvasive and invasive types, detailing distinguishing features, aggressive behaviors, and distinct genomic alterations of various subtypes like micropapillary, plasmacytoid, and small cell…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
At the Society of Urologic Oncology Annual Meeting, Katie S. Murray, DO, NYU Grossman School of Medicine, and Christopher Wallis, MD, PhD, FRCSC, University …
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
At the Society of Urologic Oncology Annual Meeting, Bishoy Faltas, MD, Weill Cornell Medicine, and Christopher Wallis, MD, PhD, FRCSC, University of Toronto,…
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
Erdafitinib or chemotherapy in advanced or metastatic #UrothelialCarcinoma. Arlene Siefker-Radtke @MDAndersonNews joins @UroCancerMD @VUMCurology to discuss the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer > https://t.co/epYXJJTgk8 https://t.co/qrnDWeT0mb